文献速递流行病学与生物统计临床试验与 GCP

安慰剂对照手术试验关键方法学问题报告有待改进:一项系统综述

Reporting of key methodological issues in placebo-controlled trials of surgery needs improvement: a systematic review.
PubMed 文献 · J Clin Epidemiol · 2019-11-28

多数试验为胃肠手术(42%)和微创操作(46%),仅少数报告安慰剂使用理由、患者信息提供及干预标准化与 fidelity 监测,关键方法学报告不一致,亟需指南优化透明度。

要点

  • 多数手术安慰剂对照试验针对小型或微创操作,样本量常小于100例。
  • 仅约三分之一试验报告使用安慰剂的理由,患者信息提供报告率仅11%。
  • 干预标准化和实施监测的报告率极低(分别为7%和4%)。

核心结论

  • 手术安慰剂对照试验多评价小型手术,关键方法学报告不一致,需要指南优化报告透明度。

主要发现

  • 超过三分之二的试验随机化少于100例患者(n=65,68%),三分之一为单中心(n=31,32%)。
  • 三分之一(n=33,34%)未报告使用安慰剂的理由。
  • 最常见的降低患者风险策略为操作者技能(n=22,23%)和独立数据监测(n=28,29%)。
  • 仅11项(11%)报告向患者提供关于安慰剂使用的信息;43项试验(45%)向安慰剂组患者提供治疗干预。

关键数值与推荐

  • 64项试验(67%)声明组间麻醉匹配。
  • 尝试标准化干预和监测实施情况的试验分别为7项(7%)和4项(4%)。

临床怎么用

  • 临床解读手术安慰剂对照试验时需注意其方法学报告常不完整,应谨慎评估偏倚风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To examine key methodological considerations for using a placebo intervention in randomized controlled trials (RCTs) evaluating invasive procedures, including surgery. STUDY DESIGN AND SETTING: RCTs comparing an invasive procedure with a placebo were included in this systematic review. Articles published from database inception to December 31, 2017, were retrieved from Ovid MEDLINE, Ovid EMBASE and CENTRAL electronic databases, by handsearching references and expert knowledge. Data on trial characteristics (clinical area, nature of invasive procedure, number of patients and centers) and key methodological (rationale for using placebos, minimization of risk, information provision, offering the treatment intervention to patients randomized to placebo, delivery of cointerventions, and intervention standardization and fidelity) were extracted and summarized descriptively. RESULTS: One hundred thirteen articles reporting 96 RCTs were identified. Most were conducted in gastrointestinal surgery (n = 40, 42%) and evaluated minimally invasive procedures (n = 44, 46%). Over two-thirds randomized fewer than 100 patients (n = 65, 68%) and a third were single center (n = 31, 32%). A third (n = 33, 34%) did not report a rationale for using a placebo. Most common strategies to minimize patient risk were operator skill (n = 22, 23%) and independent data monitoring (n = 28, 29%). Provision of patient information regarding placebo use was infrequently reported (n = 11, 11%). Treatment interventions were offered to patients randomized to placebo in 43 trials (45%). Cointerventions were inconsistently reported, but 64 trials (67%) stated that anesthesia was matched between groups. Attempts to standardize interventions and monitor their delivery were reported in n = 7, (7%) and n = 4, (4%) trials, respectively. CONCLUSION: Most placebo-controlled trials in surgery evaluate minor surgical procedures and currently there is inconsistent reporting of key trial methods. There is a need for guidance to optimize the transparency of trial reporting in this area.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Cousins S, Blencowe NS, Tsang C, et al. Reporting of key methodological issues in placebo-controlled trials of surgery needs improvement: a systematic review. J Clin Epidemiol. 2019. PMID: 31786153. doi:10.1016/j.jclinepi.2019.11.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。